SMCHD1 (structural maintenance of chromosomes flexible hinge domain containing protein 1) has been implicated in X-chromosome inactivation, imprinting and DNA damage repair. Mutations in SMCHD1 can also cause facioscapulohumoral muscular dystrophy. More recently, SMCHD1 has also been detected as component of telomeric chromatin. Here, we identify requirements of SMCHD1 for DNA damage signaling and non-homologous end joining (NHEJ) at unprotected telomeres. Co-depletion of SMCHD1 with TRF2 reduced the rate of 3' overhang removal in time course experiments and the number of telomere end fusions. In SMCHD1 deficient cells, the formation of ATM pS1981, gH2AX and 53BP1 containing telomere dysfunction induced foci (TIFs) were diminished indicating defects in checkpoint signaling. Strikingly, removal of TPP1 and subsequent activation of ATR signaling rescued telomere fusion events in TRF2-depleted SMCHD1 knockout cells. Together, these data indicate that SMCHD1 depletion reduces telomere fusions in TRF2-depleted cells due to defects in ATM-dependent DNA checkpoint signaling. SMCHD1 mediates DNA damage signaling activation upstream of ATM phosphorylation at uncapped telomeres.
Introduction
Arguably the most fundamental function of telomeres is to suppress at chromosome ends DNA damage signaling and DNA end repair (Muller, 1938; McClintock, 1941) . This is achieved through the recruitment of specialized proteins that bind directly or indirectly to telomeric repeat DNA, which consists of hundreds to thousands of 5'-TTAGGG-3'/5'-CCCTAA-3' repeats in vertebrates. Most abundant at telomeres are the shelterin proteins comprising TRF1, TRF2, RAP1, TIN2, TPP1 and POT1 (de Lange, 2018; Lazzerini-Denchi & Sfeir, 2016) . TRF1 and TRF2 bind as homodimers to the double stranded telomeric DNA repeats. Depletion of TRF2 from chromosome ends occurs naturally upon telomere shortening in senescent cells (Karlseder et al, 2002; Cesare et al, 2013) . TRF2 depletion leads to ATM kinase activation and a long-lasting DNA damage response (DDR) promoting cellular senescence (Denchi & de Lange, 2007) or apoptosis (Karlseder et al, 1999) . Inactivation of the DDR in senescent cells occurs during tumorigenesis (Shay & Wright, 2011; Maciejowski & de Lange, 2017) . The ensuing cell proliferation leads to further telomere shortening and further TRF2 depletion culminating in telomere crisis in which chromosome ends are fused to one another by alternative nonhomologous DNA end joining (alt-NHEJ), which relies on DNA ligase 3 and poly(ADP-ribose) polymerase 1 (PARP1) (Jones et al, 2014) . Experimental depletion of TRF2 in cells with normal telomere length also leads to ATM-dependent DDR activation and telomere end joining, which in this case is mediated by the classical NHEJ pathway involving DNA ligase 4 and the KU70/80 heterodimer (Celli & de Lange, 2005) . Significantly, classical NHEJ at TRF2-depleted telomeres requires DDR activation (Denchi & de Lange, 2007) .
The DDR promotes genome stability regulating DNA repair, chromatin remodeling, transcription, cell cycle arrest, senescence and apoptosis (Ciccia & Elledge, 2010; Panier & Durocher, 2013) . DDR activation at DNA double strand breaks and uncapped telomeres involves ATM recruitment to chromatin by the MRE11/RAD50/NBS1 (MRN) complex, which also promotes conformational changes stimulating ATM kinase activity (Paull, 2015) . In addition to the interaction with NBS1 in the MRN complex, ATM activation also depends on Tip60/KAT5-dependent acetylation of K3016 in ATM (Sun et al, 2009) . Active ATM leads to autophosphorylation at S1981 and phosphorylation and activation of hundreds of downstream DDR substrates (Matsuoka et al, 2007) , such as the CHK2 kinase, p53, NBS1, 53BP1 and H2AX.
SMCHD1 is a non-canonical member of the structural maintenance of chromosomes (SMC) protein family (Blewitt et al, 2008) , which includes among others the SMC1/3 cohesion and SMC2/4 condensin complex components, the SMC5/6 complex which is involved in homologous recombination and RAD50. As other SMC proteins, SMCHD1 contains a hinge domain flanked by coiled-coil domains. However, unlike SMC1-6, SMCHD1 forms homodimers (Brideau et al, 2015) . Furthermore, it contains a GHKL (gyrase, Hsp90, histidine kinase, MutL)-type ATPase rather than the bipartite ABC-type ATPase domain typically seen in SMC proteins (Brideau et al, 2015) .
Several studies implicate roles of SMCHD1 in modulating chromosome architecture at the inactive X chromosome and at Hox clusters (Nozawa et al, 2013; Wang et al, 2018; Jansz et al, 2018; Gdula et al, 2019) . SMCHD1 mediates the compaction of the inactive X chromosome in females linking the H3K9me3 and the XIST-H3K27me3 domains (Nozawa et al, 2013) . Through mediating chromatin interactions on the inactive X chromosome, SMCHD1 may also promote chromatin mixing and drive attenuation of chromosomal compartments and topologically associated domains (TADs) (Wang et al, 2018) . SMCHD1 localization to the inactive X chromosome in mouse cells is dependent on a pathway involving the Xist long noncoding RNA, Hnrnp K and PRC1 (Jansz et al, 2018) . Alternative mechanisms of SMCHD1 recruitment to chromatin may involve H3K9me3, HP1g and affinity for nucleic acids (Nozawa et al, 2013) . Apart from binding the inactive X chromosome, SMCHD1 is also recruited to sites of DNA damage induced by laser micro-irradiation (Coker & Brockdorff, 2014) or zeocin drug treatment and it has been implicated in promoting DNA repair by NHEJ over homologous recombination (Tang et al, 2014) . Finally, SMCHD1 has been detected in proteomic analyses of telomeric chromatin (Déjardin & Kingston, 2009; Grolimund et al, 2013; Bartocci et al, 2014) . Specifically, SMCHD1 was enriched at telomeres that were overly long and showed a lower density of TRF2 (Grolimund et al, 2013) . However, the roles of SMCHD1 at telomeres remained enigmatic.
Here, we discover critical functions of SMCHD1 at telomeres that were deprived of TRF2. Significantly, depletion of SMCHD1 impairs with ATM-dependent DNA damage signaling at TRF2-depleted telomeres. At the same time telomere end fusions were diminished indicating crucial roles of SMCHD1 in DNA damage signaling or repair. Experimental activation of the ATR checkpoint at TRF2-depleted telomeres reinstigated chromosome end fusions in the absence of SMCHD1 unraveling a requirement of SMCHD1 for checkpoint activation but not directly the DNA repair reaction. Our data indicate that SMCHD1 is required promoting ATM dependent DDR activation.
Results

SMCHD1 is required for efficient telomere-end-to-end fusions at TRF2-depleted telomeres
In previous work we observed in HeLa cells enrichment of SMCHD1 at long telomeres with an average length of 30 kb over telomeres with an average length of 10 kb (Grolimund et al, 2013) . In addition, over-elongated telomeres showed a lower density of TRF2. We therefore tested if shRNA-mediated TRF2 depletion in HeLa cells is sufficient to enhance association of SMCHD1 with telomeres of normal length. SMCHD1 association with telomeric DNA was assessed by chromatin immunoprecipitation upon which co-precipitated telomeric DNA was detected by Southern hybridization. Indeed, immunoprecipitated SMCHD1 was associated with more telomeric DNA in TRF2depleted cells ( Fig EV1) . A probe for Alu-repeat DNA served as a negative control.
TRF2-depleted telomeres trigger an ATM-dependent DNA damage response and they undergo NHEJ-mediated telomere end-to-end fusions (Denchi & de Lange, 2007) .
In order to assess potential roles of SMCHD1 for these processes, we used CRISPR/Cas9 technology to disrupt the SMCHD1 gene and we developed shRNA vectors for the depletion of SMCHD1 (Fig 1) . Three different guide RNAs were used for generating SMCHD1 knockout clones in HeLa cells and in a HeLa cell clone in which TRF2 could be depleted using an inducible shRNA (Grolimund et al. 2013) . Individual clones were screened for loss of SMCHD1 protein expression on Western blots using antibodies recognizing SMCHD1 peptides near the N-and C-termini ( Fig 1A and Fig EV2A) . This analysis suggested complete loss of SMCHD1 protein expression in all three clones ( Fig   EV2A) . Analysis of the knockout clones by PCR amplification of the targeted loci and DNA sequencing revealed introduction of frameshift mutations near the N-terminus of SMCHD1 leading to premature stop codons ( Fig EV2B) , which can explain the loss of SMCHD1 protein expression. In addition, two shRNAs mediated efficient depletion of SMCHD1 protein ( Fig EV3 and further below) . ShRNA-mediated TRF2 depletion during 5 days ( Fig 1A) triggered end-to-end fusions at 20% of the chromosome ends as assessed by the analysis of metaphase chromosome spreads (Fig 1B,C) . Strikingly, the telomere fusions were reduced to roughly 3-4% when TRF2 was depleted in two different SMCHD1 knockout clones. Similar results were obtained upon shRNA-mediated codepletion of SMCHD1 with TRF2 ( Fig EV3) confirming critical roles of SMCHD1 for efficient telomere end-to-end fusions upon TRF2 loss. The effects of SMCHD1-loss on telomere end-to-end fusions were not due defects in cell cycle progression as the cell cycle profile was not strongly affected in SMCHD1 knockout cells versus WT ( Fig 1D) .
SMCHD1 promotes DNA end processing for NHEJ at TRF2-depleted telomeres
Upon TRF2-depletion, telomeric DNA is first processed to remove the 3' overhang. The blunt end telomeres are then fused by NHEJ (Celli & de Lange, 2005) . To better understand the roles of SMCHD1 in these processes, we followed telomeric DNA processing and fusions in time-course experiments in which TRF2 was depleted using an inducible shRNA in SMCHD1 wild type and knockout cells (Fig 2A) . Quantification of telomere end-to-end fusions showed again strong reduction but not abolishment of fusion events in SMCHD1 knockout cells ( Fig 2B) . Removal of the telomeric 3' overhang was assessed by native in gel hybridization in which the radiolabeled probe detects only the telomeric 3' overhang but not the double stranded telomeric DNA, which remains basepaired ( Fig 1C, left panel) . As expected the overhang signal was lost upon in vitro treatment of the DNA prior to gel loading with Exonuclease 1 from E. coli which removes the 3' overhang (left panel, lanes designated with +Exo). Upon denaturation of the same gel, however, single and double stranded telomeric DNA is detected with the probe (right panel). Inspection of the native gels ( Fig 2C, left panel, see short run) and quantification revealed that the SMCHD1 knockout cells lost the telomeric 3' overhang considerably slower than the SMCHD1 wild-type cells ( Fig 2C) . Furthermore, the signal for fused telomeres which is fully double stranded and therefore can only be detected in the denatured gel ( Fig 2C, right panel, see long run), was strongly reduced in the SMCHD1 knockout cells (compare signal of fused to non-fused telomeres in each lane).
These results are consistent with the metaphase chromosome analysis of Figures 1B,C and 2B. During the time course, we also observed a shift of the telomeric signals over time towards longer telomeres which was expected as TRF2 negatively regulates telomere elongation by telomerase (Smogorzewska et al, 2000) . Telomere elongation was also apparent on the native gel indicating that these telomeres were not fused. Altogether, this analysis indicated that the first step of the telomeric DNA end-fusion reaction, the DNA end processing step was strongly delayed in the absence of SMCHD1.
SMCHD1 promotes ATM activation and DDR at TRF2-depleted telomeres
NHEJ of TRF2-depleted telomeres is strictly dependent on activation of the DDR at uncapped telomeres (Denchi & de Lange, 2007) . Therefore, we tested if SMCHD1 is required for checkpoint signaling. As expected, TRF2-depletion during 5 days led to induction of telomere dysfunction induced foci (TIFs) (Takai et al, 2003) in which at S1981 phosphorylated ATM (ATM pS1981), phosphorylated H2AX (gH2AX) and 53BP1 accumulate as foci at telomeres (Fig 3) . Strikingly, depletion of TRF2 in the two SMCHD1 knockout clones showed a strong reduction but not abolishment of all TIF markers indicating reduced DDR at TRF2-depleted telomeres in the absence of SMCHD1. Similarly, we observed reduced TIFs in TRF2-depleted cells that had been treated with SMCHD1 shRNAs ( Fig EV4) . Finally, we observed in Western blots, that ATM pS1981 was reduced in TRF2-depleted SMCHD1 knockout cells ( Fig. 1A) or upon shRNA-mediated depletion of SMCHD1 ( Fig EV3A) . Altogether, these results indicate that SMCHD1 is required for efficient ATM activation and the subsequent DDR at TRF2-depleted telomeres. Notably, however, SMCHD1 is not absolutely essential for the DDR. Thus SMCHD1 loss has less severe consequences than MRE11 depletion, which completely abolished DDR and NHEJ at TRF2-depleted telomeres ( 
SMCHD1 is nonepistatic with TERRA and MDC1
The above analyses indicated that SMCHD1 is required for efficient ATM signaling at uncapped telomeres. TRF2 depletion also leads to upregulation of the long noncoding RNA TERRA which is thought to activate the nuclease activity of MRE11 promoting the interaction between MRE11 and its activating lysine demethylase LSD1 (Porro et al, 2014b (Porro et al, , 2014a . TERRA upregulation occurs independently of ATM and principally, TERRA could act with SMCHD1 upstream of ATM or it could function in a separate pathway. We therefore tested if SMCHD1 is required for the induction of TERRA expression upon TRF2 depletion quantifying TERRA stemming from different chromosome ends by RT-qPCR (Feretzaki & Lingner, 2017) ( Fig EV5) . The quantification of TERRA demonstrated that TERRA induction upon TRF2-depletion occurs in SMCHD1-knockout as well as in WT cells indicating that SMCHD1 is not required for TERRA induction.
Another factor implicated in TIF formation at uncapped telomeres stimulating chromosome end-to-end fusions is MDC1 (Dimitrova & de Lange, 2006) . We determined the epistatic relationship of SMCHD1 and MDC1 for TIF formation upon TRF2 loss, depleting MDC1 with shRNAs in WT and SMCHD1 knockout cells ( Fig   EV6) . As expected TIF formation was reduced upon deletion of SMCHD1 or depletion of MDC1. Significantly, TIF formation was further reduced upon MDC1 depletion in SMCHD1 knockout cells unraveling additive effects. Therefore, the two factors behaved in a non-epistatic manner suggesting that SMCHD1 does not directly cooperate with MDC1 for DNA damage signaling. The latter is also consistent with the notion that in contrast to SMCHD1 (Fig 2) , MDC1 is not required for efficient removal of the 3' overhang indicating that it functions further downstream (Dimitrova & de Lange, 2006) .
SMCHD1 is not required for genome-wide ATM signaling
ATM activation at uncapped chromosome ends may involve distinct steps that do not occur upon induction of chromosome breaks elsewhere in the genome. We tested in time course experiments if SMCHD1 is required for ATM activation at chromosome breaks induced by g-irradiation and if SMCHD1 influences ATM foci disappearance that occurs upon DNA repair (Fig 4) . In addition, we followed accumulation and disappearance of DNA damage markers on Western blots. CHK2 which acts downstream of ATM becomes phosphorylated at T68. CHK1 and RPA become phosphorylated by ATR. In the time course experiments, no striking difference was observed between WT and SMCHD1 knockout cells with regard to foci accumulation and disappearance and the overall accumulation and disappearance of DNA damage markers (Fig 4) . Therefore, we conclude that for the bulk of DNA damage sites that were induced by g-irradiation, SMCHD1 played no crucial role for DNA damage signaling and DNA repair.
SMCHD1 is required for NHEJ at TRF2-depleted telomeres because of DNA damage response signaling activation
The above results unraveled requirements of SMCHD1 for ATM activation and NHEJ of TRF2-depleted telomeres but they could not distinguish if the effects on NHEJ were solely due to its involvement in checkpoint activation or if SMCHD1 also played direct roles in the DNA processing or end ligation reactions. For addressing this question we were inspired by a previous landmark paper (Denchi & de Lange, 2007) , which discovered the requirement of ATM for NHEJ of TRF2-depleted telomeres and which demonstrated that ATM function could be substituted by activated ATR. To activate ATR at telomeres, we depleted TPP1 with shRNAs ( Fig 5A) , which leads to removal of POT1 from the telomeric 3' overhang (Frescas & de Lange, 2014) . This in turn leads to RPA binding to the single stranded 3' overhang, subsequent ATR/ATRIP recruitment and checkpoint signaling at chromosome ends (Zou & Elledge, 2003) . Significantly, the shRNA-mediated depletion of TPP1 reinstated efficient chromosome end-to-end fusions in SMCHD1 knockout cells that had been depleted for TRF2 ( Fig 5B) . Concomitant inhibition of the ATR kinase with an inhibitor (VE-821) (Reaper et al, 2011) again prevented efficient end fusions ( Fig 5C) indicating that ATR signaling upon TPP1depletion was responsible for triggering chromosome end-to-end fusions in the absence of SMCHD1.
Discussion
In this paper we demonstrate that loss of SMCHD1 abolishes efficient DNA damage signaling and NHEJ at telomeres that are depleted of TRF2. The defects of SMCHD1 knockout cells in signaling and repair can be ascribed to its roles in DDR activation ( Fig   6) . Indeed, activation of ATR upon depletion of TPP1 was sufficient to suppress the defects of the SMCHD1 knockout for NHEJ at TRF2-depleted telomeres suggesting that SMCHD1 is required for checkpoint signaling but it is not directly involved in NHEJ.
Since SMCHD1 loss in TRF2-depleted cells strongly attenuated ATM activation, our data indicate that SMCHD1 functions in the DDR cascade upstream of ATM phosphorylation ( Fig 6) . During canonical ATM-dependent DDR at DNA double strand breaks, the MRN complex binds and senses DNA ends recruiting and activating ATM, which then initiates the DNA damage signaling cascade (Paull, 2015) . At telomeres, the MRN complex is present even when telomeres are intact (Zhu et al, 2000) . Indeed, NBS1 of the MRN complex interacts directly with TRF2 but in this context, ATM is not activated (Rai et al, 2017) . TRF2 inhibits ATM signaling by several mechanisms involving its TRFH and hinge domains (Okamoto et al, 2013) . The TRFH domain of TRF2 promotes formation of t-loops, which prevents exposure of the chromosome ends to the MRN complex not allowing ATM recruitment or activation (Doksani et al, 2013; Van Ly et al, 2018) . In addition, the TRFH domain of TRF2 interacts at intact telomeres with a non-phosphorylated form of NBS1 preventing ATM activation (Rai et al. 2017) .
Second, through a portion of the hinge domain of TRF2 referred to as iDDR, TRF2 can sever the DDR at the level of the E3 ubiquitin ligase RNF168 which is required for 53BP1 localization to telomeres (Okamoto et al, 2013) . Upon TRF2 removal, NBS1 is phosphorylated by CDK2 at Ser432 (Rai et al, 2017) . The t-loops will unwind and MRE11/RAD50 may associate with the uncapped telomeres possibly at their DNA ends in a similar manner as it does with DNA double strand breaks (Syed & Tainer, 2018) .
Phosphorylated NBS1 may bind to uncapped telomeres via MRE11 enabling ATM recruitment and activation (Rai et al, 2017) .
Our data implicate SMCHD1 at the onset in the damage signaling cascade. We infer that SMCHD1 is not required for t-loop unwinding as its function at uncapped telomeres could be reinstated upon ATR activation ( Fig 5) and checkpoint kinases have not been implicated in t-loop unwinding (Van Ly et al, 2018) . SMCHD1 promotes ATM activation as in its absence ATM is not efficiently phosphorylated and ATM pS1981 does not accumulate substantially in TIFs ( Fig 6) . SMCHD1 contains an N-terminal ATPase domain and a C-terminal hinge domain mediating homodimerization (Brideau et al, 2015) . We speculate that SMCHD1 may promote ATP-dependent chromatin remodeling at telomeres upon t-loop unfolding. A role in chromatin architecture and remodeling would be analogous to the functioning of other SMC proteins (van Ruiten & Rowland, 2018) and consistent with the described roles of SMCHD1 in modulating chromosome structure (Nozawa et al, 2013; Wang et al, 2018; Jansz et al, 2018; Gdula et al, 2019) .
For example, SMCHD1 may modulate the telomere structure at TRF2-depleted telomeres at the molecular level to expose telomeric DNA ends and favor MRE11 remodeling thus assisting ATM recruitment and activation (Fig 6) . This function of SMCHD1 appears not to involve TERRA induction which occurs upon TRF2-depletion independently of SMCHD1 and ATM. Our epistatic analyses with MDC1 also suggest that SMCHD1 and MDC1 act at separate steps in DNA damage signaling.
At the inactive X chromosome in females, SMCHD1 has been implicated in chromosome compaction linking H3K9me3 rich with H3K27me3 rich domains (Nozawa et al, 2013) . At telomeres, however, we did not detect notable effects of SMCHD1 depletion on telomere compaction (data not shown). Thus, although H3K9me3 may be important for SMCHD1 binding to uncapped telomeres, SMCHD1-loss does not alter chromatin compaction at telomeres at detectable levels as seen at the inactive X chromosome.
ATM activation is not only required for NHEJ of uncapped telomeres but also for NHEJ of a subset of DNA breaks which occur in heterochromatic regions of the genome (Goodarzi et al, 2008) . It has been proposed that ATM signaling at DNA breaks temporarily perturbs heterochromatin to promote processing of otherwise inflexible chromatin (Goodarzi et al, 2008) . We tested if SMCHD1 promotes also ATM activation at DNA breaks induced by g-irradiation elsewhere in the genome. Our data indicate that SMCHD1 plays no essential role for damage signaling by ATM and DNA repair for the majority of damage sites that were induced by g-irradiation. Nevertheless, we do not exclude that SMCHD1 participates in damage signaling at other specialized regions of the genome which possibly adopt a heterochromatic structure similar to telomeres.
Consistent with this notion are previous observations, which demonstrated recruitment of SMCHD1 to laser-beam induced sites of DNA damage (Coker & Brockdorff, 2014; Tang et al, 2014) . However, our data do not support a general role of SMCHD1 in ATM activation and DNA repair. They unravel for the first time specific roles of SMCHD1 at uncapped telomeres to trigger damage signaling activation and we determine that its requirement for NHEJ at uncapped telomeres is solely explained by its contribution to the DDR.
ATM activation upon telomere shortening and TRF2 depletion contributes to the induction of cell cycle arrest and cellular senescence (d'Adda di Fagagna et al, 2003) .
Our results implicate SMCHD1 in damage signaling from unprotected telomeres.
Mutations in SMCHD1 have been linked to several diseases including facioscapulohumoral muscular dystrophy (FSHD) and Bosmia arhinia (Jansz et al, 2017) .
It will be important to determine if disease mutations also impact on DNA damage signaling from telomeres and to what extent this may affect disease pathology.
Materials and methods
Cell culture
HeLa cells harboring 11 kb long telomeres as well as the HeLa cells containing an inducible shTRF2 knockdown cassette cell lines were described previously (Grolimund et al, 2013) . They were used for all transient transfection experiments and to derive SMCHD1 knockout clones. Cells were maintained at 37°C with 5% CO2 in Dulbecco's modified Eagle's medium supplemented with 10% FCS and penicillin/streptomycin. For the experiment in Figure 5 , WT and SMCHD1 knockout cells were seeded at 0.5x10 6 cells per dish. They were irradiated 14 hours post seeding with 3 grays of total γ-irradiation dosage and harvested after the indicated times for Western blot and indirect immunofluorescence analysis.
Antibodies
The following primary antibodies were used: TRF2 (#05-521, Millipore, mouse, dilution 1:1,000, used for Western blots (WB)), γH2AX (Millipore, #05-636, mouse, dilution 1:1,000, used for WB and IF), hnRNPA1 (4B10, #sc-32301, Santa Cruz Biotechnology, mouse, dilution 1:3,000, used for WB), 53BP1 (#NB100-304, Novus Biologicals, rabbit, dilution 1:2,000, used for IF), phospho-ATM-Ser1981 (#ab81292, Abcam, rabbit, dilution 1:1,000, used for WB and IF), SMCHD1 (#A302-871A, Bethyl Laboratories, Nterminal, rabbit, dilution 1:2,000, used for WB and ChIP), SMCHD1 (#A302-872A, Bethyl Laboratories, C-terminal, rabbit, dilution 1:2,000, used for WB and ChIP), TPP1 (#H00065057-M02, Abnova, rabbit, dilution 1:1,000, used for WB), MRE11 (#NB100-142, Novus Biologicals, rabbit, dilution 1:2,000, used for WB), MDC1 (#ab11171, Abcam, rabbit, dilution 1:1,000, used for WB), normal rabbit IgG (#sc-2027, rabbit, used for ChIP).
Plasmids
Plasmids containing shRNAs used in this study were prepared by restriction cloning of annealed oligonucleotides into pSUPERpuro or pSUPERblast plasmid backbones (Oligoengine TM ). The target sequences of the shRNAs were: Figure   2C ) and separated by regular gel electrophoresis in 1 × TBE at 3 V cm −1 for 1 h (Short run) and at 1.5 V cm −1 for 16h (Long run). Gels were dried for 3h at 50°C, prehybridized at 50°C in Church buffer (1%BSA, 1mM EDTA, 0.5M phosphate buffer pH 7.5, 7%SDS) and hybridized at 50°C overnight to a [ 32 P]-labeled (CCCTAA)n probe (Grolimund et al, 2013) for detection of single stranded (ss) telomeric DNA. After hybridization, the gel was rinsed in 4 × SSC and followed by successive 1 h washes at 50°C in 4 × SSC, 4 × SSC/0.5% SDS and 2 × SSC/0.5% SDS and exposed to a sensitive phosphoimager screen overnight. After the image was acquired the gel was denatured with 0.8 M NaOH and 150 mM NaCl, neutralized with 1.5 M NaCl, 0.5 M Tris-HCl pH 7.0, prehybridized in Church buffer at 50° for 1h and incubated with the same probe overnight at 50°C. The gel was again washed and exposed as above and the image was acquired using Amersham TM Typhoon TM Biomolecular imager (GE Healthcare). The images were quantified using Aida Image Analysis software. The single stranded-DNA signal was divided by the total denatured DNA signal in each lane and further normalized to -Dox samples.
CRISPR/Cas9 gene editing
The CRISPR/Cas9 gene editing system was used to create SMCHD1 knockout cell lines.
To target the SMCHD1 gene locus (NC_000018.10; gene ID 23347), a region of 200 bp encompassing the ATG in Exon 1 was submitted to the Optimal CRISPR design tool (http://crispr.mit.edu). Three gRNAs with scores higher than 93 were chosen for further experiments (gRNA 1: 5'-CTTGTTTGATCGGCGCGAAA-3', gRNA2: 5'-GGGGAGCGCTCGGACTACGC-3', gRNA 3: 5'-GCCGTCCGCCGCTGCCATAT-3').
Complementary oligonucleotides harbouring the guide RNA sequence and BpiI Scientific, #11668019). Transfected cells were selected with 1µg/mL of puromycin for 4 days. Single-cell clones were obtained by limiting dilution and were screened for the absence of SMCHD1 by Western blotting using the N-terminal anti-SMCHD1 antibody.
To verify the gene editing in positive clones, the PCR products obtained with 2 primers (AV48_SMCHD1_gPCR_F: 5'-AGGAGCGCGTTTGAATCGG-3', AV47_SMCHD1_gPCR_R 5'-CTTCGCGTACCTGACACACAC-3') were TOPOcloned (Thermo Fisher, #450071) and sent for sequencing.
Telomeric PNA-FISH on metaphase spreads
On the day of harvesting, cells were treated with 0.1 μg/mL demecolcine (Sigma Aldrich Chemie GmbH #D7385-10MG) for 2 h, cells were collected, resuspended in hypotonic solution (0.056 M KCl) and swollen for 7 min. Swollen cells were fixed in methanol:acetic acid (3:1) and stored overnight at 4°C. The next day cell suspensions were dropped onto slides to prepare metaphase spreads, incubated 1min at 70°C in a wet chamber and dried for 16-24 h before FISH. FISH staining of human telomeric DNA was performed as described (Vancevska et al, 2017) . Slides were rehydrated in 1× PBS for 5 min, treated with 4% formaldehyde in PBS for 5 min, washed 3x with 1xPBS and dehydrated with increasing amounts of ethanol (70%, 95%, 100%). Dehydrated slides were then placed on coverslips containing 70 µL hybridization mix (10 mM Tris-HCl, 2% blocking reagent (Roche, #11096176001), 70% formamide and 0.1 µM Cy3 labeled (CCCTAA)3 PNA probe (PNA Bio, #F1002)) and denatured at 80°C for 3 min in a hybridization oven. Subsequently, the hybridization was allowed to proceed for 3h in a light protected humified chamber at 25 °C. The coverslip was then removed from the slide, washed twice for 15 min in buffer containing 70% formamide and 10 mM Tris-HCl pH 7.4 and 3 times for 15 min with 0.1 M Tris-HCl pH 7.2, 0.15 M NaCl, 0.08% Tween-20. For DNA staining, DAPI was added to 1 µg/ml in the second wash. After the washes slides were stored at 4°C in a dark place until imaging.
Indirect immunofluorescence and telomeric FISH (IF-FISH)
Indirect immunofluorescence detection of human ATM pS981, 53BP1 and γH2AX followed by telomeric FISH staining was performed as described (Vancevska et al. 2017 ). For detection of ATM pS1981 before crosslinking, cells were fractionated with an ice-cold preextraction buffer containing 0.5% Triton X-100, 20mM HEPES-OH pH 7.5, 50mM NaCl, 3mM MgCl2 and 300mM sucrose for 7min. Subsequently cells were washed with 1xPBS and the same protocol was applied as for the other stainings.
Chromatin Immuno Precipitation (ChIP)
ChIP protocol for SMCHD1 and γH2AX was performed as described previously (Grolimund et al. 2013) . Briefly, 10 million cells per condition were harvested and washed with 1xPBS pH 7.4. The cell pellet was then crosslinked in 1mL 1% formaldehyde in 1xPBS pH 7.4 for 15min at RT. Glycine pH 2.5 was added to 125mM to quench the reaction, incubated for 5min and cells were then washed 3x with 1xPBS pH 7.4. Cells were subsequently incubated 5min in 1mL lysis buffer (1% SDS, 10 mM EDTA pH 8.0, 50 mM Tris-Cl pH 8.0, EDTA-free protease inhibitor complex (Roche, #11836170001)), centrifuged 5min at 2,000g and the chromatin enriched pellet was again resuspended in 500µL lysis buffer and subjected to sonication for 30min (30s ON, 30s
OFF, total sonication time 15min) using BioruptorÒ Twin Diogenode sonicatior (#UCD-400). The sonicated lysate was centrifugated at 20,000g for 15min at 4°C. Per IP 100µL of the cleared lysate was diluted with 9 volumes of IP buffer (1.2 mM EDTA pH 8.0, Telomeric and Alu-repeat DNA were detected successively using the conditions described before. After the exposure the image was acquired using FujiFilm Fluorescent Image Analyzer FLA-3000 and the image quantification was done using AIDA Image Analyzer software v 4.06.
Cell cycle analysis
For analysis of the cell cycle distribution of SMCHD1 KO cells, propidium iodide stained cells were analysed by Fluorescence Activated Cell Sorting (FACS). For each sample 2x10 6 cells were pelleted, washed in 1xPBS and fixed by dropwise addition of 1mL of ice-cold 70% ethanol and incubated at least 24h hours. Following the fixation, cells were resuspended in 250µL 1xPBS containing 0.2µg/mL of RNAseA and incubated for 15min at 37°C. Cells were then stained by addition of 250µL of 1xPBS containing 80µg/mL propidioum iodide and incubated at 4°C for 10min. Subsequently, cells were passed through a strainer and analysed by FACS on Accuri C6 (BD Biosciences). The percentage of cells in each phase of the cell cycle was determined using the Watson Pragmatic computational model in FlowJo software (TreeStar).
RT-qPCR for measuring TERRA transcript levels
TERRA was measured as previously described (Feretzaki & Lingner, 2017) 
